Karyopharm Therapeutics Inc. Profile Avatar - Palmy Investing

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes nov…

Biotechnology
US, Newton [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Karyopharm Therapeutics Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of KPTI's Analysis
CIK: 1503802 CUSIP: 48576U106 ISIN: US48576U1060 LEI: - UEI: -
Secondary Listings
KPTI has no secondary listings inside our databases.